Pharma Surge

Pharma Surge

Global Pharma News & Pipeline

1 ratings
Free
In-App Purchases

Rating summary
1
0
0
0
0

Details

  • Released
  • Updated
  • March 9, 2026
  • March 27, 2026

Features

Pharma Surge screenshot #1 for iPhone
Pharma Surge screenshot #2 for iPhone
Pharma Surge screenshot #3 for iPhone
Pharma Surge screenshot #4 for iPhone
Pharma Surge screenshot #5 for iPhone
Pharma Surge screenshot #6 for iPhone
Pharma Surge screenshot #7 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

This app provides global pharmaceutical and biotech news, monitoring companies, regulatory agencies, clinical trials, and medical developments. It offers curated updates, analytics, and personalized tracking to transform raw information into actionable insights for industry professionals.

Curated news briefs
Company and industry analytics
Clinical trial pipeline tracking
Personalized topic monitoring
Article saving and note-taking
Background data synchronization
Show original description

What's New in Pharma Surge

2.6

March 27, 2026

This is a minor update focused on Brief content loading reliability. No new permissions or entitlements have been added beyond those already approved in 2.5. Changes in this version: Article Feed Display Fix — Fixed an issue introduced in 2.5.1 where the "Latest" and "Global" tabs in the Brief section could appear blank or show incomplete article lists on some devices after updating. Cache Recovery Improvement — Improved local cache recovery so the app can rebuild article lists from live API data when older cached data becomes stale or inconsistent. Background Content Sync Reliability — Improved refresh and fallback behavior so feed updates are applied more consistently after the daily pipeline completes. Performance Optimization — Improved overall feed loading stability and reliability in the Brief section. Review path: Open the app → "Brief" tab → switch to "Latest" and "Global" → verify that article lists load correctly and no longer appear blank or incomplete. Then open "Briefing" to confirm the daily briefing still loads normally. No login is required for browsing.

More

Subscription plans

Pro Monthly

Unlimited access to all Pro features

$2.991 Month
How to cancel Pharma Surge subscription ⁉️

Developer apps

FAQ

What is Pharma Surge?

Pharma Surge is a global pharmaceutical intelligence platform that monitors companies, regulatory agencies, clinical trials, and medical developments. It aims to help industry professionals quickly gain actionable insights from news and data.

What features are available for free in Pharma Surge?

The free version of Pharma Surge provides access to 'Brief' updates and 'Pipeline' tracking. This allows users to stay informed about key developments in the pharmaceutical and biotech sectors.

What does the Pro version of Pharma Surge offer?

The Pro version of Pharma Surge unlocks advanced features including 'Analytics' for company insights and industry heatmaps, and 'Track' for personalized monitoring of important topics. These features provide deeper intelligence for strategic workflows.

How often is Pharma Surge updated?

The app was last updated on March 27, 2026, with version 2.6. Updates have focused on improving article coverage, date format handling, content filtering, and background data synchronization for a more complete experience.

Is Pharma Surge available on multiple devices?

Yes, Pharma Surge is supported on Mac, iPhone, and iPad. This allows users to access pharmaceutical intelligence across different Apple devices.

Does Pharma Surge provide medical advice?

No, Pharma Surge aggregates publicly available information for research and business intelligence purposes only. It does not provide medical advice and should not be used for diagnosis or treatment decisions.

What is the user sentiment for Pharma Surge?

Based on the available data, Pharma Surge has a perfect rating of 5.0 stars from 1 rating. This indicates a highly positive initial user experience.

Does Pharma Surge have ads?

No, Pharma Surge does not contain advertisements. Users can access the platform without interruptions from ads.